Inspire Medical Systems, Inc. Share-based Payment Arrangement, Expense
Inspire Medical Systems, Inc. (INSP) reported Share-based Payment Arrangement, Expense of $9.72 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2022-05-03
- Inspire Medical Systems, Inc. share-based payment arrangement, expense for the quarter ending 2022-03-31 was $9.72M, a 62.10% increase year-over-year.
- Inspire Medical Systems, Inc. share-based payment arrangement, expense for the quarter ending 2021-12-31 was $7.03M, a 82.41% increase year-over-year.
- Inspire Medical Systems, Inc. share-based payment arrangement, expense for the quarter ending 2021-09-30 was $6.81M, a 105.68% increase year-over-year.
- Inspire Medical Systems, Inc. share-based payment arrangement, expense for the quarter ending 2021-06-30 was $6.34M, a 118.43% increase year-over-year.
- Inspire Medical Systems, Inc. share-based payment arrangement, expense for fiscal 2021 was $26.18M, a 104.24% increase from fiscal 2020.
- Inspire Medical Systems, Inc. share-based payment arrangement, expense for fiscal 2020 was $12.82M, a 106.83% increase from fiscal 2019.
- Inspire Medical Systems, Inc. share-based payment arrangement, expense for fiscal 2019 was $6.20M, a 408.37% increase from fiscal 2018.
- Inspire Medical Systems, Inc. share-based payment arrangement, expense for fiscal 2018 was $1.22M, a 401.65% increase from fiscal 2017.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2022-03-31 | $9.72M 10-Q · filed 2022-05-03 | $16.75M derived: sum of 2 quarters · filed 2022-05-03 | $23.56M derived: sum of 3 quarters · filed 2022-05-03 | $29.90M derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-12-31 | $7.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $13.84M derived: sum of 2 quarters · filed 2022-02-15 | $20.18M derived: sum of 3 quarters · filed 2022-02-15 | $26.18M 10-K · filed 2022-02-15 |
| 2021-09-30 | $6.81M 10-Q · filed 2021-11-02 | $13.15M derived: sum of 2 quarters · filed 2021-11-02 | $19.15M 10-Q · filed 2021-11-02 | $23.00M derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-06-30 | $6.34M 10-Q · filed 2021-08-03 | $12.34M 10-Q · filed 2021-08-03 | $16.19M derived: sum of 3 quarters · filed 2022-05-03 | $19.50M derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-03-31 | $6.00M 10-Q · filed 2022-05-03 | $9.85M derived: sum of 2 quarters · filed 2022-05-03 | $13.16M derived: sum of 3 quarters · filed 2022-05-03 | $16.07M derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $7.17M derived: sum of 2 quarters · filed 2022-02-15 | $10.07M derived: sum of 3 quarters · filed 2022-02-15 | $12.82M 10-K · filed 2022-02-15 |
| 2020-09-30 | $3.31M 10-Q · filed 2021-11-02 | $6.21M derived: sum of 2 quarters · filed 2021-11-02 | $8.96M 10-Q · filed 2021-11-02 | $10.86M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $2.90M 10-Q · filed 2021-08-03 | $5.65M 10-Q · filed 2021-08-03 | $7.54M derived: sum of 3 quarters · filed 2022-02-15 | $9.07M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $2.75M 10-Q · filed 2021-05-04 | $4.64M derived: sum of 2 quarters · filed 2022-02-15 | $6.17M derived: sum of 3 quarters · filed 2022-02-15 | $7.55M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $3.42M derived: sum of 2 quarters · filed 2022-02-15 | $4.81M derived: sum of 3 quarters · filed 2022-02-15 | $6.20M 10-K · filed 2022-02-15 |
| 2019-09-30 | $1.52M 10-Q · filed 2020-11-02 | $2.91M derived: sum of 2 quarters · filed 2020-11-02 | $4.30M 10-Q · filed 2020-11-02 | $4.83M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $1.39M 10-Q · filed 2020-08-04 | $2.78M 10-Q · filed 2020-08-04 | $3.30M derived: sum of 3 quarters · filed 2021-02-24 | $3.67M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $1.39M 10-Q · filed 2020-05-05 | $1.91M derived: sum of 2 quarters · filed 2021-02-24 | $2.29M derived: sum of 3 quarters · filed 2021-02-24 | $2.56M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $895.00K derived: sum of 2 quarters · filed 2021-02-24 | $1.16M derived: sum of 3 quarters · filed 2021-02-24 | $1.22M 10-K · filed 2021-02-24 |
| 2018-09-30 | $372.00K 10-Q · filed 2019-11-05 | $641.00K derived: sum of 2 quarters · filed 2019-11-05 | $696.00K 10-Q · filed 2019-11-05 | $750.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $269.00K 10-Q · filed 2019-08-06 | $324.00K 10-Q · filed 2019-08-06 | $378.00K derived: sum of 3 quarters · filed 2020-02-25 | $459.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $55.00K 10-Q · filed 2019-05-07 | $109.00K derived: sum of 2 quarters · filed 2020-02-25 | $190.00K derived: sum of 3 quarters · filed 2020-02-25 | $244.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $135.00K derived: sum of 2 quarters · filed 2020-02-25 | $189.00K derived: sum of 3 quarters · filed 2020-02-25 | $243.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $81.00K 10-Q · filed 2018-11-06 | $135.00K derived: sum of 2 quarters · filed 2018-11-06 | $189.00K 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $54.00K 10-Q · filed 2018-08-07 | $108.00K 10-Q · filed 2018-08-07 | ||
| 2016-12-31 | $248.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |